Search





Search





Markets
/
Stocks
/
nasdaq-bcax
/

Bicara Therapeutics Inc

BCAX

Add to Watchlist

20.230USD

-0.420-2.03%

Close 05/15, 16:00（ET）Quotes delayed by 15 min

1.33BMarket Cap

LossP/E TTM



Bicara Therapeutics Inc

20.230

-0.420-2.03%

Overview Financials Discussions Analysis Company

Overview

Financials

Discussions

Analysis

Company

Cash Flow Statement

You can access the annual and quarterly cash flow statements of Bicara Therapeutics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q1

FY2023Q3

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-33.45%-37.51M

20.46%-23.89M

-69.81%-29.25M

---25.59M

-92.68%-28.11M

---30.03M

-63.54%-17.22M

---14.59M

---10.53M

Net income from continuing operations

-52.56%-56.21M

-78.39%-37.39M

-107.83%-36.33M

---27.39M

-194.58%-36.85M

---20.96M

23.48%-17.48M

---12.51M

---22.84M

Operating gains losses

131.58%44.00K

186.67%43.00K

60.00%24.00K

--19.00K

46.15%19.00K

--15.00K

650.00%15.00K

--13.00K

--2.00K

Other non-cash items

342.75%611.00K

305.07%566.00K

313.24%281.00K

--211.00K

112.31%138.00K

---276.00K

161.54%68.00K

--65.00K

--26.00K

Change in working capital

137.53%12.19M

170.38%8.44M

270.33%3.16M

---1.93M

255.33%5.13M

---11.99M

-18.89%-1.86M

---3.30M

---1.56M

-Change in prepaid expenses

-49.25%2.09M

105.06%839.00K

-178.70%-301.00K

--627.00K

1851.49%4.12M

---16.57M

-532.00%-108.00K

---235.00K

--25.00K

-Change in payables and accrued expense

791.75%10.37M

84.33%7.89M

325.46%3.78M

---2.38M

138.75%1.16M

--4.28M

-6.14%-1.68M

---3.00M

---1.58M

Cash from non-recurring investing activities

Cash from operating activities

-33.45%-37.51M

20.46%-23.89M

-69.81%-29.25M

---25.59M

-92.68%-28.11M

---30.03M

-63.54%-17.22M

---14.59M

---10.53M

Investing cash flow

Net cash from continuing investing activities

--60.00K

495.00%238.00K

425.00%42.00K

--0.00

100.00%0.00

--40.00K

-94.67%8.00K

---58.00K

--150.00K

Capital expenditures

--60.00K

495.00%238.00K

425.00%42.00K

--0.00

-100.00%0.00

--40.00K

-94.67%8.00K

--4.00K

--150.00K

Net cash flow from disposal of fixed assets

--60.00K

495.00%238.00K

425.00%42.00K

--0.00

100.00%0.00

--40.00K

-94.67%8.00K

---58.00K

--150.00K

Net cash flow from investment products

--101.00M

---82.09M

---236.08M

----

Net cash flow from other investing activities

----

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

--100.94M

-205730.00%-82.33M

-2951412.50%-236.12M

--0.00

-100.00%0.00

---40.00K

94.67%-8.00K

--58.00K

---150.00K

Financing cash flow

Cash flow from continuous financing activities

35409.78%163.34M

3303.08%31.23M

-99.87%436.00K

--135.00K

235.77%460.00K

---975.00K

737.39%334.13M

--137.00K

--39.90M

Net cash flow from common stock issuance/repurchase

--161.76M

2903.99%29.50M

----

---1.05M

--333.48M

----

Proceeds from stock option exercised by employees

243.91%1.58M

2149.35%1.73M

626.67%436.00K

--135.00K

235.77%460.00K

--77.00K

-28.57%60.00K

--137.00K

--84.00K

Net cash flow from other financing activities

----

-100.00%0.00

----

--596.00K

----

Net cash from non-recurrent financing activities

Net cash from financing activities

35409.78%163.34M

3303.08%31.23M

-99.87%436.00K

--135.00K

235.77%460.00K

---975.00K

737.39%334.13M

--137.00K

--39.90M

Net cash flow

Beginning cash balance

-80.26%96.69M

-67.03%171.67M

114.17%436.61M

--462.06M

112.51%489.71M

--520.76M

1259.94%203.85M

--230.44M

--14.99M

Current period cash flow changes

920.29%226.78M

-141.53%-74.99M

-183.60%-264.93M

---25.46M

-92.09%-27.65M

---31.05M

984.54%316.90M

---14.39M

--29.22M

Ending cash balance

-30.00%323.46M

-80.26%96.69M

-67.03%171.67M

--436.61M

113.87%462.06M

--489.71M

1077.92%520.76M

--216.05M

--44.21M

Free cash flow

-33.67%-37.57M

19.78%-24.12M

-69.97%-29.29M

---25.59M

-92.63%-28.11M

---30.07M

-61.32%-17.23M

---14.59M

---10.68M

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

